Logo image of MYSZ

MY SIZE INC (MYSZ) Stock Fundamental Analysis

NASDAQ:MYSZ - US62844N4060 - Common Stock

1.19 USD
+0.01 (+0.85%)
Last: 9/3/2025, 4:30:01 PM
1.2 USD
+0.01 (+0.84%)
After Hours: 9/3/2025, 4:30:01 PM
Fundamental Rating

2

Overall MYSZ gets a fundamental rating of 2 out of 10. We evaluated MYSZ against 280 industry peers in the Software industry. The financial health of MYSZ is average, but there are quite some concerns on its profitability. MYSZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MYSZ has reported negative net income.
In the past year MYSZ has reported a negative cash flow from operations.
In the past 5 years MYSZ always reported negative net income.
In the past 5 years MYSZ always reported negative operating cash flow.
MYSZ Yearly Net Income VS EBIT VS OCF VS FCFMYSZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

MYSZ's Return On Assets of -46.11% is on the low side compared to the rest of the industry. MYSZ is outperformed by 84.29% of its industry peers.
MYSZ has a worse Return On Equity (-66.93%) than 75.00% of its industry peers.
Industry RankSector Rank
ROA -46.11%
ROE -66.93%
ROIC N/A
ROA(3y)-65.37%
ROA(5y)-90.51%
ROE(3y)-125.25%
ROE(5y)-153.85%
ROIC(3y)N/A
ROIC(5y)N/A
MYSZ Yearly ROA, ROE, ROICMYSZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

MYSZ has a worse Gross Margin (37.72%) than 76.43% of its industry peers.
In the last couple of years the Gross Margin of MYSZ has declined.
The Profit Margin and Operating Margin are not available for MYSZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
MYSZ Yearly Profit, Operating, Gross MarginsMYSZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

4

2. Health

2.1 Basic Checks

MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MYSZ has been increased compared to 1 year ago.
The number of shares outstanding for MYSZ has been increased compared to 5 years ago.
The debt/assets ratio for MYSZ has been reduced compared to a year ago.
MYSZ Yearly Shares OutstandingMYSZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
MYSZ Yearly Total Debt VS Total AssetsMYSZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

MYSZ has an Altman-Z score of -9.30. This is a bad value and indicates that MYSZ is not financially healthy and even has some risk of bankruptcy.
MYSZ has a worse Altman-Z score (-9.30) than 87.86% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that MYSZ is not too dependend on debt financing.
MYSZ has a Debt to Equity ratio (0.03) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -9.3
ROIC/WACCN/A
WACC9.51%
MYSZ Yearly LT Debt VS Equity VS FCFMYSZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 3.02 indicates that MYSZ has no problem at all paying its short term obligations.
MYSZ has a better Current ratio (3.02) than 77.50% of its industry peers.
MYSZ has a Quick Ratio of 2.05. This indicates that MYSZ is financially healthy and has no problem in meeting its short term obligations.
MYSZ has a better Quick ratio (2.05) than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 3.02
Quick Ratio 2.05
MYSZ Yearly Current Assets VS Current LiabilitesMYSZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

MYSZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.11%, which is quite impressive.
The Revenue for MYSZ has decreased by -27.08% in the past year. This is quite bad
MYSZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 165.15% yearly.
EPS 1Y (TTM)72.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.07%
Revenue 1Y (TTM)-27.08%
Revenue growth 3Y297.97%
Revenue growth 5Y165.15%
Sales Q2Q%-50.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.88%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MYSZ Yearly Revenue VS EstimatesMYSZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
MYSZ Yearly EPS VS EstimatesMYSZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 -100 -200 -300

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MYSZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MYSZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSZ Price Earnings VS Forward Price EarningsMYSZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSZ Per share dataMYSZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 -3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MYSZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MY SIZE INC

NASDAQ:MYSZ (9/3/2025, 4:30:01 PM)

After market: 1.2 +0.01 (+0.84%)

1.19

+0.01 (+0.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)N/A N/A
Inst Owners0.68%
Inst Owner Change262.58%
Ins Owners3.54%
Ins Owner Change0%
Market Cap3.88M
Analysts82.86
Price Target3.06 (157.14%)
Short Float %0.85%
Short Ratio0.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B 0.64
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-3.58
EYN/A
EPS(NY)-2.75
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)-0.9
OCFYN/A
SpS2.07
BVpS1.85
TBVpS1.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.11%
ROE -66.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.72%
FCFM N/A
ROA(3y)-65.37%
ROA(5y)-90.51%
ROE(3y)-125.25%
ROE(5y)-153.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.02
Quick Ratio 2.05
Altman-Z -9.3
F-Score4
WACC9.51%
ROIC/WACCN/A
Cap/Depr(3y)6.12%
Cap/Depr(5y)22.62%
Cap/Sales(3y)0.26%
Cap/Sales(5y)5.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.07%
EPS Next Y33.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.08%
Revenue growth 3Y297.97%
Revenue growth 5Y165.15%
Sales Q2Q%-50.44%
Revenue Next Year12.88%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.1%
OCF growth 3YN/A
OCF growth 5YN/A